HIGHLIGHTS
- who: Thomas Ku00f6hnke from the Department of Medicine III, University Hospital, LMU Munich, Marchioninistr, Munich, Germany have published the paper: Integrated multiomic approach for identification of novel immunotherapeutic targets in AML, in the Journal: (JOURNAL)
- what: Taken together the authors demonstrate the feasibility of a highly optimized surfaceome detection method to interrogate the entire AML surfaceome directly from primary patient samples and integrate this data with gene expression and mutational burden data to achieve a robust multiomic target identification platform. This approach has the potential to accelerate the unbiased target identification for immunotherapy of AML . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.